Powder: -20°C for 3 years | In solvent: -80°C for 1 year
lumateperone Tosylate (ITI-007) is a 5-HT2A receptor antagonist (Ki: 0.54 nM), a SERT blocker (Ki: 61 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki: 32 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 80.00 | |
25 mg | In stock | $ 163.00 | |
50 mg | In stock | $ 243.00 | |
100 mg | In stock | $ 359.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 59.00 |
Description | lumateperone Tosylate (ITI-007) is a 5-HT2A receptor antagonist (Ki: 0.54 nM), a SERT blocker (Ki: 61 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki: 32 nM). |
Targets&IC50 | SERT:61 nM (Ki), 5-HT2A receptor:0.54 nM (Ki) |
In vitro | Lumateperone also possesses an affinity for the D1 receptor (Ki: 52 nM) and weak affinity for the α1A- and α1B-adrenergic receptors (Ki: 173 nM at α1) and D4 receptor. Lumateperone does not significantly bind to the 5-HT2B, 5-HT2C, H1, or mACh receptors. Lumateperone shows a 60-fold difference in its affinities for the 5-HT2A and D2 receptors, which is far greater than that of most or all existing atypical antipsychotics, such as risperidone (12-fold), olanzapine (12.4-fold), and aripiprazole (0.18-fold). |
Synonyms | ITI-007 |
Molecular Weight | 565.7 |
Formula | C31H36FN3O4S |
CAS No. | 1187020-80-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (433.09 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
lumateperone Tosylate 1187020-80-9 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor ITI-007 schizophrenia Inhibitor inhibit dopamine D1 receptor 5-HT2A 5-hydroxytryptamine Receptor ITI 007 presynaptic D2 receptor Lumateperone ITI007 postsynaptic D2 receptor Serotonin Receptor inhibitor